Bausch + Lomb reported a remarkable turnaround in the third quarter, swinging to a net income of $32 million, or 9 cents a share, compared with a loss of $28 million, or 8 cents a share, a year earlier. The eye-health company's improved financial performance has led it to raise its outlook for the full year. The profitability marks a significant shift from the previous year's loss, signaling strengthening demand and operational improvements within the company's core eye-care business.
This financial rebound positions Bausch + Lomb to exceed its earlier guidance and potentially expand its market presence in the competitive eye-health sector.
Source: Wall Street Journal US Business · Summarized by HeadlinesBriefing